These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
585 related articles for article (PubMed ID: 29282686)
1. Perspectives of Reprogramming Breast Cancer Metabolism. Wang YP; Lei QY Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686 [TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. Yoshida GJ J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347 [TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer. El-Sahli S; Wang L Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266219 [TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function. Martinez-Outschoorn U; Sotgia F; Lisanti MP Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293 [TBL] [Abstract][Full Text] [Related]
5. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer. Lao L; Fan S; Song E Adv Exp Med Biol; 2017; 1026():331-370. PubMed ID: 29282692 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive Proteomics Analysis Reveals Metabolic Reprogramming of Tumor-Associated Macrophages Stimulated by the Tumor Microenvironment. Liu D; Chang C; Lu N; Wang X; Lu Q; Ren X; Ren P; Zhao D; Wang L; Zhu Y; He F; Tang L J Proteome Res; 2017 Jan; 16(1):288-297. PubMed ID: 27809537 [TBL] [Abstract][Full Text] [Related]
7. The Role of Sodium Hydrogen Exchanger 1 in Dysregulation of Proton Dynamics and Reprogramming of Cancer Metabolism as a Sequela. Cardone RA; Alfarouk KO; Elliott RL; Alqahtani SS; Ahmed SBM; Aljarbou AN; Greco MR; Cannone S; Reshkin SJ Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357694 [TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA. Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981 [TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell metabolism: a potential target for cancer therapy. Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361 [TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion. Yan L; Wu M; Wang T; Yuan H; Zhang X; Zhang H; Li T; Pandey V; Han X; Lobie PE; Zhu T Cancer Res; 2024 Apr; 84(8):1270-1285. PubMed ID: 38335272 [TBL] [Abstract][Full Text] [Related]
11. Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells. Li L; Bi Z; Wadgaonkar P; Lu Y; Zhang Q; Fu Y; Thakur C; Wang L; Chen F Semin Cancer Biol; 2019 Aug; 57():10-18. PubMed ID: 31009762 [TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression. Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737 [TBL] [Abstract][Full Text] [Related]
13. Reprogramming of central carbon metabolism in cancer stem cells. Wong TL; Che N; Ma S Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1728-1738. PubMed ID: 28502706 [TBL] [Abstract][Full Text] [Related]
14. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review). Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813 [TBL] [Abstract][Full Text] [Related]
15. Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment. Pires BR; DE Amorim ÍS; Souza LD; Rodrigues JA; Mencalha AL Anticancer Res; 2016 Nov; 36(11):5681-5691. PubMed ID: 27793889 [TBL] [Abstract][Full Text] [Related]
16. Metabolic crosstalk in the breast cancer microenvironment. Dias AS; Almeida CR; Helguero LA; Duarte IF Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications. Gandhi N; Das GM Cells; 2019 Jan; 8(2):. PubMed ID: 30691108 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial OXPHOS Induced by RB1 Deficiency in Breast Cancer: Implications for Anabolic Metabolism, Stemness, and Metastasis. Zacksenhaus E; Shrestha M; Liu JC; Vorobieva I; Chung PED; Ju Y; Nir U; Jiang Z Trends Cancer; 2017 Nov; 3(11):768-779. PubMed ID: 29120753 [TBL] [Abstract][Full Text] [Related]
19. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells. Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205 [TBL] [Abstract][Full Text] [Related]
20. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy. Yan L; Tan Y; Chen G; Fan J; Zhang J Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]